Trpm2 Transient Receptor Potential Melastatin 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TRPM2 (Transient Receptor Potential Cation Channel Subfamily M Member 2) encodes a calcium-permeable nonselective cation channel activated by oxidative stress and ADP-ribose. It is widely expressed in the brain and immune cells and plays important roles in oxidative stress response, insulin secretion, and cell death pathways. [1]
| Property | Value | [2]
|----------|-------| [3]
| Gene Symbol | TRPM2 |
| Full Name | Transient Receptor Potential Cation Channel Subfamily M Member 2 |
| Chromosome | 21q22.12 |
| HGNC ID | HGNC:12339 |
| Ensembl ID | ENSG00000086848 |
| RefSeq | NM_003307 |
TRPM2 is a unique channel with several distinctive features:
The TRPM2 protein contains:
| Approach | Status | Description |
|---|---|---|
| TRPM2 Antagonists | Preclinical | ADC (8-chloro-4-hydroxyphenyl) etc. |
| Calcium Channel Blockers | Approved | Non-specific approaches |
| Antioxidants | Approved | Reduce oxidative stress activation |
| Gene Therapy | Experimental | Silencing TRPM2 expression |
The study of Trpm2 Transient Receptor Potential Melastatin 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.